Proto Labs, Inc. (PRLB) AI Stock Analysis

Proto Labs, Inc. operates as a digital manufacturer specializing in custom prototypes and on-demand production parts through a global e-commerce platform. It provides manufacturing services including injection molding, computer numerical control (CNC) machining, sheet metal fabrication, and various 3D printing technologies such as stereolithography, selective laser sintering, and direct metal laser sintering. Serving developers and engineers using 3D CAD software, the company supports end markets including automotive, aerospace, medical devices, consumer electronics, and industrial equipment. Its digital operational model combines technology and automation to enable rapid prototyping and low- to medium-volume production with quick turnaround times.

Proto Labs grew revenue from $488.1M in FY2021 to $533.1M in FY2025, posting a 5-year revenue CAGR of 4.2% from FY2020 to FY2025. Annual net income shifted from $33.4M in FY2021 to -$103.5M in FY2022, before recovering to $17.2M in FY2023, $16.6M in FY2024, and $21.2M in FY2025. Annual gross margin stood at 44.5% in FY2025, while operating margin was 4.9%. Over the trailing twelve months, revenue reached $560.5M with a profit margin of 5.4% and an operating margin of 8.8%. In the latest quarter ended June 30, 2026, quarterly revenue grew 10.6% year-over-year, and quarterly earnings expanded 105.6%.

As of June 30, 2026, Proto Labs held $142.8M in cash and short-term investments and $2.2M in total debt, resulting in net cash of $140.5M and a debt-to-equity ratio of 0.00. Total assets were $791.3M against shareholders' equity of $691.7M, supporting a current ratio of 3.64. In FY2025, operating cash flow was $74.5M and free cash flow was $59.7M. Capital expenditures were $14.8M, and the company allocated $43.0M to share buybacks in FY2025, contributing to an 11.6% reduction in share count over 5 years.

At a last close of $85.65 on October 16, 2026, Proto Labs had a market capitalization of $2.05B and an enterprise value of $1.99B. The stock trades at a trailing P/E of 68.0x and a forward P/E of 32.3x, compared to medians of 24.8x and 17.2x, respectively, for the median of its US-listed Industrials peers. Its EV-to-EBITDA multiple of 27.0x is also above the peer median of 13.9x, while its PEG ratio stands at 0.86. Over the trailing year, PRLB gained 57.1% compared to a 16.8% return for SPY, though its 5-year return of 20.9% trailed the index's 83.0% gain.

Wall Street coverage includes 3 Strong Buy, 1 Buy, and 1 Hold rating, with no Sell or Strong Sell ratings. The mean price target is $95.50, representing an upside of 11.5% from the last close of $85.65. For the fiscal year ending December 31, 2026, analysts estimate EPS of $2.21 on revenue of $582.4M. For the following fiscal year, 4 analysts project EPS of $2.39 and revenue of $626.5M. The company beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is October 29, 2026.

This page is an AI-written research summary of Proto Labs, Inc. (PRLB). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: PRLB income statement, PRLB balance sheet, PRLB key metrics, PRLB analyst forecast, PRLB chart. See the PRLB stock overview for the latest quote and news.